Cleavage of host keratin 8 by a chlamydia-secreted protease

Infection and Immunity

Volumn 72, Issue 7, 2004, Pages 3863-3868

  Dong, Feng ^a   Su, Heng ^a   Huang, Yanqing ^a   Zhong, Youmin ^a   Zhong, Guangming ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b The University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIAL PROTEASE PROTEASOME LIKE ACTIVITY FACTOR; KERATIN; KERATIN 8; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL REPRODUCTION; CELL VACUOLE; CHLAMYDIA; CHLAMYDIASIS; CYTOSKELETON; EPITHELIUM CELL; EUKARYOTE; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

CHLAMYDIA; CHLAMYDIA INFECTIONS; CYTOSOL; ENDOPEPTIDASES; HELA CELLS; HOST-PARASITE RELATIONS; HUMANS; KERATIN-8; KERATINS;

EID: 3042546262     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.7.3863-3868.2004     Document Type: Article

References (33)

1. Askienazy-Elbhar, M., and J. H. Suchet. 1999. Persistent "silent" Chlamydia trachomatis female genital tract infections. Infect. Dis. Obstet. Gynecol. 7:31-34.
2. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:686-699.
3. Casanova, L., A. Bravo, F. Were, A. Ramirez, J. J. Jorcano, and M. Vidal. 1995. Tissue-specific and efficient expression of the human simple epithelial keratin 8 gene in transgenic mice J. Cell Sci. 108:811-820.
4. Chen, P. H., D. A. Ornelles, and T. Shenk. 1993. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J. Virol. 67:3507-3514.
5. Ditzel, H. J., M. C. Strik, M. K. Larsen, A. C. Willis, A. Waseem, K. Kejling, and J. C. Jensenius. 2002. Cancer-associated cleavage of cytokeratin 8/18 heterotypic complexes exposes a neoepitope in human adenocarcinomas. J. Biol. Chem. 277:21712-21722.
6. Fan, T., H. Lu, H. Hu, L. Shi, G. A. McClarty, D. M. Nance, A. H. Greenberg, and G. Zhong. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187:487-496.
7. Hackstadt, T. 1998. The diverse habitats of obligate intracellular parasites. Curr. Opin. Microbiol. 1:82-87.
8. Hembrough, T. A., K. R. Kralovich, L. Li, and S. L. Gonias. 1996. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation. Biochem. J. 317:763-769.
9. Hembrough, T. A., L. Li, and S. L. Gonias. 1996. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J. Biol. Chem. 271:25684-25691.
10. Hembrough, T. A., J. Vasudevan, M. M. Allietta, W. F. Glass II, and S. L. Gonias. 1995. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J. Cell Sci. 108:1071-1082.
11. Hendrix, M. J., E. A. Seftor, Y. W. Chu, K. T. Trevor, and R. E. Seftor. 1996. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15:507-525.
12. Herrmann, H., and U. Aebi. 2000. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 12:79-90.
13. Herrmann, H., M. Haner, M. Brettel, S. A. Muller, K. N. Goldie, B. Fedtke, A. Lustig, W. W. Franke, and U. Aebi. 1996. Structure and assembly properties of the intermediate filament protein vimentin: the role of its head, rod and tail domains. J. Mol. Biol. 264:933-953.
14. Ichikawa, A., H. Tachibana, S. Kawamoto, M. Kamei, T. Honjoh, S. Hashizume, and S. Shirahata. 1997. Cytokeratin 8 and 19 as antigens recognized by adenocarcinoma-reactive human monoclonal antibody AE6F4. Hum. Antibodies 8:195-202.
15. Kaufmann, E., K. Weber, and N. Geisler. 1985. Intermediate filament forming ability of desmin derivatives lacking either the amino-terminal 67 or the carboxy-terminal 27 residues. J. Mol. Biol. 185:733-742.
16. Ku, N. O., J. Liao, C. F. Chou, and M. B. Omary. 1996. Implications of intermediate filament protein phosphorylation. Cancer Metastasis Rev. 15: 429-444.
17. Liebig, H. D., J. Seipelt, E. Vassilieva, A. Gradi, and E. Kuechler. 2002. A thermosensitive mutant of HRV2 2A proteinase: evidence for direct cleavage of eIF4GI and eIF4GII. FEBS Lett. 523:53-57.
18. Lopes, M. A., N. G. Nikitakis, M. A. Reynolds, R. A. Ord, and J. Sauk, Jr. 2002. Biomarkers predictive of lymph node metastases in oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 60:142-147. (Discussion, 60:147-148.)
19. Oshima, R. G., H. Baribault, and C. Caulin. 1996. Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev. 15:445-471.
20. Sauk, J. J., M. Krumweide, D. Cocking-Johnson, and J. G. White. 1984. Reconstitution of cytokeratin filaments in vitro: further evidence for the role of nonhelical peptides in filament assembly. J. Cell Biol. 99:1590-1597.
21. Schaafsma, H. E., F. C. Ramaekers, G. N. van Muijen, E. B. Lane, I. M. Leigh, H. Robben, A. Huijsmans, E. C. Ooms, and D. J. Ruiter. 1990. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am. J. Pathol. 136:329-343.
22. Schacter, J. 1977. The expanding clinical spectrum of infections with Chlamydia trachomatis. Sex. Transm. Dis. 4:116-118.
23. Seipelt, J., H. D. Liebig, W. Sommergruber, C. Gerner, and E. Kuechler. 2000. 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. J. Biol. Chem. 275:20084-20089.
24. Snasel, J., R. Shoeman, M. Horejsi, O. Hruskova-Heidingsfeldova, J. Sedlacek, T. Ruml, and I. Pichova. 2000 Cleavage of vimentin by different retroviral proteases. Arch. Biochem. Biophys. 377:241-245.
25. Strelkov, S. V., H. Herrmann, N. Geisler, T. Wedig, R. Zimbelmann, U. Aebi, and P. Burkhard. 2002. Conserved segments 1A and 2B of the intermediate filament dimer: their atomic structures and role in filament assembly. EMBO J. 21:1255-1266.
26. Wyrick, P. B. 2000. Intracellular survival by chlamydia. Cell Microbiol. 2:275-282.
27. Zhang, Y., and R. J. Schneider. 1994. Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J. Virol. 68:2544-2555.
28. Zhong, G., F. Castellino, P. Romagnoli, and R. N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:2061-2066.
29. Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942.
30. Zhong, G., T. Fan, and L. Liu. 1999. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189:1931-1938.
31. Zhong, G., L. Liu, T. Fan, P. Fan, and H. Ji. 2000. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J. Exp. Med. 191:1525-1534.
32. Zhong, G., C. Reis e Sousa, and R. N. Germain. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94:13856-13861.
33. Zhong, G. M., E. M. Peterson, C. W. Czarniecki, and L. M. de la Maza. 1988. Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo. Infect. Immun. 56:283-286.